DNA Damage Response in Quiescent Hematopoietic Stem Cells and Leukemia Stem Cells

被引:2
作者
Zhang, Wenjun [1 ]
Wang, Guangming [1 ]
Liang, Aibin [1 ]
机构
[1] Tongji Univ, Sch Med, Tongji Hosp, Dept Hematol, Shanghai, Peoples R China
来源
LEUKEMIA STEM CELLS IN HEMATOLOGIC MALIGNANCIES | 2019年 / 1143卷
基金
中国国家自然科学基金;
关键词
DNA damage; Hematopoietic stem cell; Leukemia stem cell; STRAND BREAK REPAIR; CROSS-LINK REPAIR; BCR-ABL; SELF-RENEWAL; CLONAL HEMATOPOIESIS; PYRIMIDINE DIMERS; PROGENITOR CELLS; EXCISION-REPAIR; CANCER; MECHANISMS;
D O I
10.1007/978-981-13-7342-8_7
中图分类号
Q813 [细胞工程];
学科分类号
摘要
In humans, hematopoietic stem cells (HSCs) adopt unique responsive pathways counteracting with the DNA-damaging assaults to weigh the balance between the maintenance of normal stem cell poor for whole-life blood regeneration and the transformation to leukemia stem cells (LSCs) for leukemia initiation. LSCs also take actions of combating with the attack launched by externally therapeutic drugs that can kill most leukemic cells, to avoid extermination and promote disease relapse. Therefore, the collection of knowledge about all these underlined mechanisms would present a preponderance for later studies. In this chapter, the universal DNA damage response (DDR) mechanisms were firstly introduced, and then DDR of HSCs were presented focusing on the DNA double-strand breaks in the quiescent state of HSCs, which poses a big advantage in promoting its transformation into preleukemic HSCs. Lastly, the DDR of LSCs were summarized based on the major outcomes triggered by different pathways in specific leukemia, upon which some aspects for future investigations were envisioned under our currently limited scope of knowledge.
引用
收藏
页码:147 / 171
页数:25
相关论文
共 110 条
  • [21] DNA single-strand break repair
    Caldecott, Keith W.
    [J]. EXPERIMENTAL CELL RESEARCH, 2014, 329 (01) : 2 - 8
  • [22] PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways
    Chang, L.
    Graham, P. H.
    Hao, J.
    Ni, J.
    Bucci, J.
    Cozzi, P. J.
    Kearsley, J. H.
    Li, Y.
    [J]. CELL DEATH & DISEASE, 2014, 5 : e1437 - e1437
  • [23] Molecular regulation of stem cell quiescence
    Cheung, Tom H.
    Rando, Thomas A.
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2013, 14 (06) : 329 - 340
  • [24] The DNA Damage Response: Making It Safe to Play with Knives
    Ciccia, Alberto
    Elledge, Stephen J.
    [J]. MOLECULAR CELL, 2010, 40 (02) : 179 - 204
  • [25] Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126
  • [26] A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms
    Cojoc, Monica
    Maebert, Katrin
    Muders, Michael H.
    Dubrovska, Anna
    [J]. SEMINARS IN CANCER BIOLOGY, 2015, 31 : 16 - 27
  • [27] Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission
    Corces-Zimmerman, M. Ryan
    Hong, Wan-Jen
    Weissman, Irving L.
    Medeiros, Bruno C.
    Majeti, Ravindra
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (07) : 2548 - 2553
  • [28] BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders: some common and contrasting features
    Cross, N. C. P.
    Daley, G. Q.
    Green, A. R.
    Hughes, T. P.
    Jamieson, C.
    Manley, P.
    Mughal, T.
    Perrotti, D.
    Radich, J.
    Skoda, R.
    Soverini, S.
    Vainchenker, W.
    Verstovesk, S.
    Villeval, J. -L
    Goldman, J. M.
    [J]. LEUKEMIA, 2008, 22 (11) : 1975 - 1989
  • [29] DNA repair dysregulation from cancer driver to therapeutic target
    Curtin, Nicola J.
    [J]. NATURE REVIEWS CANCER, 2012, 12 (12) : 801 - 817
  • [30] DNA interstrand crosslink repair and cancer
    Deans, Andrew J.
    West, Stephen C.
    [J]. NATURE REVIEWS CANCER, 2011, 11 (07) : 467 - 480